CAPTURE 2 Post-Marketing Registry "CAPTURE 2"

Completed

Phase 4 Results

Summary of Purpose

The purposes of the registry are: 1) To provide an ongoing post-market surveillance mechanism to document clinical outcomes. 2) To provide additional information that the RX ACCULINKâ„¢ and RX ACCUNETâ„¢ can be used safely by a wide range of physicians under commercial use conditions. 3) To evaluate the adequacy of Abbott Vascular's physician training program.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 December 2012.

1 Mar 2006 10 Mar 2006 1 Mar 2010 1 May 2010 1 Dec 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment
  • Observation: Case Control
  • Perspective: Prospective
  • Sampling: Non-Probability Sample

Contacts

  • Gary Walker, Ph.D Abbott Vascular Vascular Solutions Santa Clara, CA 95054 Phone: 408-845-0538 Email: gwalker@guidant.com William A. Gray, MD Center for Interventional Vascular Therapy Columbia University Medical Center Cardiovascular Research Foundation New York, NY 10032

    wg2131@columbia.edu